D-penicillamine therapy of neonatal jaundice: comparison with phototherapy.
A total 330 newborns suffering from haemolytic disease of the newborn and hyperbilirubinaemia was treated with D-penicillamine. The therapy resulted in a significant decrease in the frequency of exchange transfusions and of high serum bilirubin levels among preterm and fullterm babies with or without sensitization. Concerning the drug's mechanism of action, reduction of the bilirubin level is achieved by means of the copper stored in the liver. The intravenous route is suggested for application of the drug. In preterm infants D-penicillamine treatment proved more effective than phototherapy.
D000284:Administration, Oral; D003300:Copper / Q000172:deficiency / Q000378:metabolism; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy; D007231:Infant, Newborn; D007234:Infant, Premature; D007275:Injections, Intravenous; D007567:Jaundice, Neonatal / Q000188:drug therapy*; D008099:Liver / Q000378:metabolism; D010396:Penicillamine / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D010778:Photochemotherapy; D011247:Pregnancy
D003300:Copper; D010396:Penicillamine